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ABSTRACT
Awareness of Pre-exposure prophylaxis (PrEP) was assessed among a cohort of substance-using
black men who have sex with men and transgender women (MSM/TGW) participating in the
STAR Study, which recruited black MSM/TGW in New York City for HIV testing and linked HIV-
infected individuals into care from July 2012 to April 2015. Sociodemographic, psychosocial,
known HIV risk factors, and PrEP awareness were assessed among participants. Multivariable
logistic regression was conducted to assess factors associated with PrEP awareness. Of 1673
participants, median age was 43 years and 25% were under age 30. Most participants (85.8%)
reported having insufficient income for basic necessities at least occasionally, 54.8% were
homeless, and 71.3% were unemployed. Awareness of PrEP was reported among 18.2% of
participants. PrEP awareness was associated with younger age (adjusted odds ratio [aOR] 0.87,
per 5 years), gay identity (aOR 2.46), higher education (aOR 1.70), more frequent past HIV testing
(aOR 3.18), less HIV stigma (aOR 0.61), less hazardous/harmful alcohol use (aOR 0.61), and more
sexual partners (aOR 1.04, per additional partner in past 30 days). In this substance-using black
MSM/TGW cohort with high rates of poverty and homelessness, PrEP awareness was low. This
study demonstrates the need for targeted dissemination of PrEP information to key populations
to increase awareness and ultimately improve uptake and utilization of PrEP.
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Introduction
Despite progress in confronting the HIV epidemic in the
US, the annual number of new infections has changed
little over the past decade (Centers for Disease Control
and Prevention, Published November, 2015). While the
US National HIV/AIDS Strategy recommends several
prevention efforts focused on black men who have sex
with men (MSM) (Office of National AIDS Policy,
2010 Jul), this population continues to be overrepre-
sented among new HIV infections (Maulsby et al.,
2014). Blacks constitute only 13.9% of the US popu-
lation, but black males represented 33.2% of adult HIV
infections in 2015, more than two thirds of which
occurred in black MSM (Centers for Disease Control
and Prevention, 2016; U.S. Census Bureau, 2015).
While the data are limited, transgender women (TGW)
also face disparities with an overall estimated HIV preva-
lence of 28%, and a 56% prevalence among black TGW
(Herbst et al., 2008).
Many factors contribute to high infection rates among
black MSM and TGW. One large multicenter study
conducted in six cities in the US found that infrequent
HIV testing, undiagnosed HIV infection, and late diag-
nosis were common among black MSM; and that new
HIV diagnoses were more common among infrequent
testers, underscoring the need for additional HIV testing
and prevention efforts in this group (Mannheimer et al.,
2014). A few studies have documented that TGW also
have high percentages of undiagnosed HIV and face
similar issues to black MSM along the HIV care conti-
nuum, from testing to engagement in care and treatment
(Schulden et al., 2008; Sevelius, Patouhas, Keatley, &
Johnson, 2014).
Daily oral emtricitabine/tenofovir disoproxil fumarate
(FTC/TDF or Truvada®), approved for use as pre-
exposure prophylaxis (PrEP) for HIV prevention in the
US since July 2012, is a potential HIV prevention strat-
egy for at risk groups, including black MSM and TGW.
When used consistently, PrEP has been associated with
as much as a 92% reduced risk of HIV acquisition in
MSM (McCormack et al., 2016; Molina et al., 2015),
and has also shown efficacy in heterosexual populations
© 2017 Informa UK Limited, trading as Taylor & Francis Group
CONTACT Matthew Garnett mfg294@gmail.com ICAP at Columbia University, Mailman School of Public Health, Columbia University, 215 West 125th
Street, Suite 100-A, New York, NY 10027, USA
AIDS CARE, 2018































(Baeten et al., 2012; Thigpen et al., 2012), albeit with con-
flicting study results (Marrazzo et al., 2015; Van Damme
et al., 2012). Mathematical modeling suggests that uptake
and adherence to PrEP could lead to a long-term
reduction in HIV incidence among MSM (Desai et al.,
2008). However, despite its evident promise, major bar-
riers remain to PrEP implementation and scale-up, par-
ticularly in populations at high risk.
Knowledge of PrEP has been reported to be low
among black MSM and TGW. A study of black MSM
in Atlanta, Georgia found that less than 25% of the par-
ticipants had knowledge of PrEP, with no improvement
noted in the 20 months following FDA approval of FTC/
TDF for PrEP (Eaton, Driffin, Bauermeister, Smith, &
Conway-Washington, 2015). Another study of MSM
patients at two New York City sexually transmitted dis-
ease (STD) clinics from 2013 to 2014 showed that less
than 40% had prior knowledge of PrEP, and none had
ever used it (Borges, Westheimer, Edelstein, Golub, &
Myers, 2014). Similarly, others have reported low levels
of awareness and uptake of PrEP among TGW (Baral
et al., 2013).
Studies have also demonstrated the value of informing
MSM about PrEP, finding that despite low initial knowl-
edge of and willingness to use PrEP, both improved with
the provision of information (Dolezal et al., 2015;
Mimiaga, Case, Johnson, Safren, & Mayer, 2009). One
study that assessed demographics and levels of interest
among MSM and TGW who were offered PrEP as part
of routine sexual health services in three US STD clinics
found that 60.5% would elect to use it. The study found
that the strongest predictors for enrollment and use
included prior PrEP awareness and having been self-
referred to obtain PrEP information. The study also
found that black MSM and TGW were less likely to
self-refer, but when adjusted for their lack of prior aware-
ness of PrEP, were just as likely to enroll as other groups
(Cohen et al., 2015). Despite these promising findings,
data from the 2014 National HIV Behavioral Surveil-
lance System has shown that actual PrEP use remains
low across US MSM populations, and that black MSM
are half as likely to use it compared to white MSM
(Hoots, Finlayson, Nerlander, & Paz-Bailey, 2016).
While some studies have examined the lack of PrEP
knowledge among black MSM and TGW, limited data
exist on sociodemographic and behavioral factors
associated with PrEP awareness among black, sub-
stance-using MSM and TGW. In this study, we report
the findings from an assessment of PrEP awareness in
this group disproportionately impacted by HIV, with
the goal of informing the development of future tar-




Data were gathered as part of the National Institute on
Drug Abuse-funded study, Seek, Test, and Retain
(STAR): Linkages for black HIV+, Substance-Using
MSM. STAR enrolled participants in New York City
from July 2012 to April 2015. The study was approved
by the Columbia University Medical Center institutional
review board (Ref IRB AAAI1585) and was registered at
ClinicalTrials.gov (NCT01790360). All study partici-
pants provided written informed consent.
The STAR Study utilized a combination of respon-
dent driven sampling, online advertising, and commu-
nity-based recruitment in neighborhoods in New York
City with high HIV prevalence to enroll the target popu-
lation for HIV testing (New York City Department of
Health and Mental Hygiene, 2015). Inclusion criteria
included being a black MSM or TGW, engaging in
anal sex with a man in the past year, and reporting any
history of alcohol to intoxication or drug use. Data for
this analysis were collected using an interviewer-admi-
nistered questionnaire completed prior to HIV testing.
The questionnaire collected information on: sociodemo-
graphic characteristics, HIV risk behavior, drug and
alcohol use, social support, trust in healthcare providers,
feelings of HIV stigma toward others, previous HIV test-
ing history, and awareness of PrEP. The population
included in this study was recruited from New York
City, where the rate of HIV diagnoses in 2013 was
33.7/100,000 residents, more than twice the rate of the
US (13.4/100,000 residents) (Centers for Disease Control
and Prevention, Published November 2015; New York
City Department of Health and Mental Hygiene, 2015).
Participants who indicated that they were HIV-negative
or had an unknown HIV status, and reported no prior
PrEP use, were included in the current analysis.
Outcome of interest
Awareness of PrEP was ascertained by asking partici-
pants “Before today, have you ever heard of PrEP”
(Yes/No) prior to testing them for HIV. Before asking
the question, participants were given a brief descrip-
tion of PrEP, and were informed that “PrEP (pre-
exposure prophylaxis) is when a person is given medi-
cine before they think they might be exposed to HIV,
to prevent becoming infected (like when they expect
they will be having sex with a partner who may
have HIV).” Additionally, participants could ask follow
up questions about PrEP and if interested, were given
information after completing the study interview and
HIV testing.































Correlates of interest included sociodemographic
characteristics such as age, sex, race, ethnicity, education,
employment, relationship status, frequency of not having
enough money to cover necessary expenses over the past
year, health insurance, and housing status. Scales were
adapted from existing validated scales to measure HIV
stigma (Visser, Kershaw, Makin, & Forsyth, 2008) and
social support (Sherbourne & Stewart, 1991). For HIV
stigma, the scale was the mean score of responses to
nine questions relating to attitudes of stigma toward
people with HIV (e.g., “I feel uncomfortable around
people with HIV.”); responses utilized a four-point
Likert scale ranging from 1 “strongly disagree” to 4
“strongly agree” (Cronbach’s alpha, 0.86). The social
support scale was calculated using the combined mean
of eight responses to questions which assessed positive
social support in the past 30 days (e.g., “During the last
30 days how often did you have someone to love and
make you feel wanted?”) and conflictual interactions
during the past 30 days (e.g. “During the past 30 days
how much of the time had serious disagreements with
your friends about things that were important to
you?”); responses utilized a five-point Likert scale ran-
ging from 1 “occurring none of the time” to 5 “occurring
all of the time” (Cronbach’s alpha, 0.72).
Alcohol use was assessed using the validated Alcohol
Use Disorders Identification Test (AUDIT), in which a
score of 8 or greater was considered hazardous/harmful
alcohol use (Saunders, Aasland, Babor, de la Fuente, &
Grant, 1993) (Cronbach’s alpha, 0.88). The validated
Texas Christian University Drug Screen-II (TCUDS-II)
was utilized to assess drug use behaviors and attitudes;
a score of 3 or more indicates problematic drug use
(Simpson, Joe, Knight, Rowan-Szal, & Gray, 2012)
(Cronbach’s alpha, 0.92).
Behavioral risk for HIV infection was operationalized
as any report of condomless anal sex and/or transac-
tional sex. Participants reported the number of vaginal
or anal sex events with any partner in the last month,
with and without use of a condom, and were considered
to have engaged in condomless sex if they reported any
episode of condomless sex. To assess transactional sex,
participants were asked if they had given or received
money, drugs, or alcohol in exchange for sex with their
main and/or casual partners within the past month.
Statistical analysis
Correlates of interest were summarized and compared
between those with and without PrEP awareness using
Pearson’s χ2, Fisher’s exact, and Wilcoxon rank sum
tests. Variables that were significant at the 0.20 alpha
level were considered for inclusion in a multivariable
logistic regression model. A multivariable model was
constructed using manual backward model selection.
Model fit was examined at the end of model selection
with the Hosmer-Lemeshow Goodness-of-Fit test. SAS




Of 1739 participants who enrolled in the STAR Study, 66
were excluded from this analysis: 33 indicated previous
use of PrEP, 23 tested HIV-positive in the past, and 10
because of missing data. The remaining 1673 partici-
pants who were included in this analysis all reported
their HIV status as either uninfected or unknown. Of
the 1673 participants, the median age was 43 years
(interquartile range 30–50); 25.0% were under the age


















Other/ Don’t know 57 3.4
Heterosexual 218 13.0
Tested HIV positive at enrollment 110 6.6
Education completed
Less than high school 491 29.4
High school 783 46.9
More than high school 396 23.7
Current employment status
Not working 1190 71.3
Working 434 26.0
Student 45 2.7




Health insurance (any) 1314 78.5
Household size (median, IQR) 1 (1, 2)
Homeless 916 54.8
General mistrust in current healthcare providers 164 9.8
HIV stigma scale (median, IQR) 1.8 (1.3, 2.0)
aPercents are out of column totals, percents may not sum to 100% due to
missing. Missing: insufficient income for necessities (7), current employ-
ment status (4), education completed (3), sexual orientation (2), transgen-































of 30, and 110 (6.6%) were found to be HIV-infected at
enrollment (Table 1). A minority (3.5%) of participants
identified as TGW; the remaining 96.5% were MSM,
with 59.9% identifying as bisexual, 23.6% as homosexual,
and 13.0% as heterosexual. Most participants (85.8%)
reported having insufficient income for basic necessities
at least occasionally, 54.8% were homeless, 71.3% were
unemployed, 21.5% did not have health insurance, and
29.4% had not graduated from high school. Overall, par-
ticipants reported low levels of HIV stigma toward
others and low levels of healthcare provider mistrust.
PrEP Awareness
Of 1673 participants, 304 (18.2%) reported PrEP
awareness. There was a gradual increase in awareness
from a level of 15.5% among the 284 participants
enrolled in 2012 to 28.3% among the 219 participants
enrolled in 2015. In bivariable analysis (Table 2), PrEP
awareness was significantly associated with younger
age (p < .001), being transgender (p < .001), identifying
as gay (p < .001), having a higher education level
(p < .001), being employed (p < .001), having sufficient
income (p = .003), living in stable housing (p = .009),
reporting low levels of HIV stigma toward others
(p < .001), less problematic drug use (p < .001), and less
hazardous/harmful alcohol use (p < .001). Marijuana
use with sex within the past month was significantly
associated with awareness (p = 0.008), but all other
drug use with sex within the past month was significantly
associated with lack of PrEP awareness (p = 0.025). PrEP
awareness was not significantly related to any sexual risk
factors. Participants who had been tested for HIV in their
lifetime and those testing at least once in the past year
were more likely to indicate PrEP awareness (p < 0.001
for both).
In multivariable analysis, as shown in Table 3, PrEP
awareness was independently associated with identifying
as gay compared to heterosexual (adjusted odds ratio
[aOR] 2.5, 95% confidence interval [CI]: 1.4–4.3), iden-
tifying as “unknown” or “other” sexual orientation com-
pared to heterosexual (aOR 2.9, 95% CI: 1.2–6.7), and
having more than a high school education compared to
less than a high school education (aOR 1.7, 95% CI:
1.1–2.6). For each additional sexual partner reported,
the odds of PrEP awareness increased by 4% (aOR 1.0,
95% CI: 1.0–1.1). The number of HIV tests reported in
the prior year was associated with PrEP awareness
(aOR 1.8, 95% CI: 1.2–2.6 for one HIV test, and aOR
3.2, 95% CI: 2.2–4.7 for getting HIV tested >2 times,
both compared to no tests in the past year). Hazar-
dous/harmful alcohol use (aOR 0.6, 95% CI: 0.5–0.8),
reporting high levels of HIV stigma toward others
(aOR 0.6, 95% CI: 0.4–0.9), and every five years of
older age (aOR 0.9, 95% CI: 0.9–0.9) were associated
with lack of PrEP awareness. There was no evidence of
poor model fit using the Hosmer-Lemeshow Good-
ness-of-Fit test.
Discussion
This study demonstrated low PrEP awareness of 18%
among a cohort of black MSM and TGW recruited
from July 2012 through April 2015 in a high HIV preva-
lence area of the US. This low awareness is underscored
by the high rate of new HIV diagnoses (6.6%) found
among study participants. Even when participants who
reported prior PrEP use are included (n = 33), only
20% of total participants had an awareness of PrEP at
study enrollment. This is lower than other published
data from the same time period, with studies showing
that 39% of black MSM and TGW and 59% of all
sampled MSM and TGW populations were aware of
PrEP (Cohen et al., 2015; Eaton et al., 2017). PrEP has
been FDA-approved in the US for five years and despite
a slow initial uptake, recent data show an increase in
PrEP prescribing for US MSM (Eaton et al., 2015; Laufer,
O’Connell, Feldman, & Zucker, 2015). However, despite
a modest increase in PrEP use noted in the literature,
awareness remains low in some populations at substan-
tial risk for HIV, which could weaken the overall impact
of PrEP use (Eaton et al., 2015).
Participants in this study who identified as gay (24%
of the cohort) and those who reported more sexual part-
ners were more likely to be aware of PrEP. Participants
who identified as gay could have more interaction with
the various sources of PrEP information, including social
networks, gay friendly venues, and gay-identified litera-
ture or media. Those with multiple partners may be
aware of their risk for HIV infection and thus may
have sought information regarding PrEP. It is also poss-
ible that those with more sexual partners may have had
more opportunities to encounter information about
PrEP either through their partners or expanded social
networks. Importantly, other behaviors associated with
increased risk of HIV infection, such as having unpro-
tected anal sex, transactional sex, or having an HIV-posi-
tive partner, were not associated with PrEP awareness.
These findings indicate that only a minority of this popu-
lation at substantial risk of HIV were aware of PrEP,
which highlights the need for intensified outreach and
education beyond traditional gay venues to reach all
MSM and TGW populations who would benefit from
PrEP.
Hazardous/harmful alcohol use was significantly
associated with low PrEP awareness. Other indicators






























Table 2. Awareness of PrEP among participants enrolled in the STAR Study, NYC 07/2012-04/2015: unadjusted analysisa.
Yes No
P-valuec
N = 304 N = 1369
n % n %
Participant demographicsb
Age in years, median (IQR) 32 (23, 45.5) 44 (32, 50) <.001*
Hispanic 91 30.0 347 25.3 0.093
Transgender 21 7.0 37 2.7 <.001*
In a relationship 47 15.5 193 14.3 0.574
Sexual orientation <.001*
Homosexual 120 39.5 275 20.1
Bisexual 138 45.4 863 63.1
Other/ Don’t know 18 5.9 39 2.9
Heterosexual 28 9.2 190 13.9
Education completed <.001*
Less than high school 79 26.0 412 30.2
High school 121 39.8 662 48.5
More than high school 104 34.2 292 21.4
Current employment status <.001*
Not working 184 60.7 1006 73.6
Working 109 36.0 325 23.8
Student 10 3.3 35 2.6
Insufficient income for necessities 0.003*
Never 49 16.2 187 13.7
Occasionally 184 60.7 723 53.0
Frequently 70 23.1 453 33.2
Health insurance (any) 238 78.3 1076 78.6 0.905
Homeless 146 48.0 770 56.2 0.009*
Substance use risk factors
Hazardous/harmful alcohol use (AUDIT)d 113 38.4 667 50.8 <.001*
Alcohol use with sex in past 30 days 173 56.9 820 59.9 0.337
Marijuana with sex in past 30 days 135 44.4 497 36.3 0.008*
Drugs with sex in past 30 days (ex: marijuana) 103 33.9 559 40.8 0.025*
Injection drug use ever 56 18.4 304 22.2 0.146
Current injection drug use 21 6.9 81 5.9 0.509
Shared needles 12 3.9 36 2.6 0.252
Yearly problematic drug use (TCUDS-II)e 144 48.8 808 60.8 <.001*
Sexual isk factors
Any unprotected sex in past month 185 60.9 873 63.8 0.318
Any unprotected anal sex in past month 170 55.9 753 55.0 0.810
Any transactional sex in past monthf 94 30.9 473 34.6 0.226
Total number of partners (median, IQR) 2 (1, 3) 2 (1, 3) 0.106
Main partner 0.165
No main partner 142 46.7 609 44.5
1 Main partner 156 51.3 702 51.3
2 Concurrent main partners 6 2.0 58 4.3
At least one main partner is male 140 46.1 577 42.2 0.213
Main partner HIV status 0.155
Negative 98 32.2 400 29.2
Positive/Unknown 64 21.1 360 26.3
No partner 142 46.7 609 44.5
One or more casual partners 187 61.5 824 60.2 0.680
Testing history
Never tested for HIV 14 4.6 160 11.7 <.001*
# of HIV tests in past year <.001*
None 69 22.7 587 42.9
1 104 34.2 482 35.2
2+ 131 43.1 300 21.9
Other
Social support scale (median, IQR)g 2.1 1.5–2.8 2.0 1.5–2.5 0.074
HIV stigma scale (median, IQR)h 1.4 (1.1, 2) 1.8 (1.3, 2) <.001*
General mistrust in current healthcare providers 30 9.9 134 9.8 0.994
a76 Participants were excluded from the analysis for indicating previous PrEP use, testing HIV positive in the past, or not answering the HIV prevention strategies
questions.
bPercents are out of column totals, percents may not sum to 100% due to missing.
cP-values are rank sum or chisq unless otherwise noted, asterisk denotes significant p-value at the .05 level.
dBased on the validated AUDIT score greater than or equal to 8.
eBased on the validated TCUDS-II drug scale, a score of 3 or more indicates problematic use.
fAssumes all missing (due to not being sexually active/ not having partners of any type) as “no”.
gScale is of mean scores where 1 is none of the time and 5 is all of the time.































of drug use, including injection drug use, assessed among
this cohort of substance-using black MSM and TGW
with high rates of poverty and homelessness, were not
associated with PrEP awareness. The low awareness of
PrEP by respondents who reported hazardous/harmful
alcohol use suggests that information regarding PrEP is
not reaching this group, and that different outreach
methods may be necessary.
Analyses showed that prior HIV testing was associated
with PrEP awareness. Individuals who had at least one
HIV test in the past year were almost twice as likely to
be aware of PrEP, and those who tested at least twice in
the past year had a more than three-fold higher likelihood
of PrEP awareness in comparison to those not tested in
the past year. This may have been due to information
received at testing sites, or that those who get more fre-
quent HIV tests weremore aware of the risk of HIV acqui-
sition and methods to prevent it, including PrEP.
Individuals who reported lower levels of externalized
stigma toward HIV-infected individuals were also more
likely to be aware of PrEP. Low or no feelings of HIV stig-
matization may relate to a broader knowledge of HIV, as
also suggested by the significant association of HIV testing
frequency and PrEP awareness. Those who indicated
lower levels of stigma about HIV may also be more likely
to seek out HIV-related services and information, while
those with higher levels of stigma may avoid seeking or
receiving HIV prevention education. This phenomenon
has been demonstrated in prior research with HIV testing,
where people who express lower levels of stigma have
been shown to be more likely to have sought HIV testing
(Kalichman & Simbayi, 2003).
Formal educational attainment was significantly
associated with PrEP awareness. Participants with
more than a high school education were almost twice
as likely to be aware of PrEP as those with less than a
high school education. Prior studies have similarly
shown that individuals with more education were more
likely to have greater knowledge of sexually transmitted
diseases and sexually transmitted disease prevention
(Garofalo et al., 2015). These findings are underscored
by the overall low levels of educational attainment
among the majority of this group. Even among the
24% of study participants that had education beyond
high school, only 26% of this group had heard about
PrEP. Although this group shows more knowledge
than participants with a high school education (15.5%)
and thoes with less than a high school education
(16.1%), it remains at a low level. While educational
venues remain potential areas of intervention, they
may not be the best way to educate this particular
group of black MSM and TGW about PrEP.
Increasing PrEP awareness is an important goal for
HIV prevention, and this analysis shows that there are
disparities in awareness within this high risk population.
Low awareness was associated with being older and
reporting hazardous alcohol use while greater awareness
was seen among participants who self identified as gay,
had multiple partners within the past month, had sought
testing in the past year, and had low feelings of stigma
towards HIV, findings that are consistent with another
major study of black MSM and TGW (Eaton et al.,
2017). Although each of these characteristics was inde-
pendently associated with higher awareness, there may
be confounding elements that drive these associations.
Although not fully assesed in this study, involvment
with a larger gay community, or an openness about
behaviors and personal willingness to seek out infor-
mation could potentially play a role in this increased
awareness. Further research is needed to explore these
Table 3.Multivariable logistic regression analysis of factors associated with awareness of PrEP, among participants enrolled in the STAR
Study, NYC 07/2012-04/2015.
Variablea Regression coefficient Standard error Adjusted OR 95% CI P-value
Age (per 5 years)* −0.135 0.007 0.87 0.86–0.88 <.0001
Hispanic 0.155 0.173 1.17 0.83–1.64 0.371
Sexual orientation
Homosexual* 0.899 0.281 2.46 1.42–4.26 0.001
Bisexual 0.113 0.269 1.12 0.66–1.90 0.675
Other/ Don’t know* 1.050 0.435 2.86 1.22–6.70 0.016
Heterosexual Ref – – – –
Education completed
Less than high school Ref – – – –
High school 0.055 0.191 1.06 0.73–1.54 0.775
More than high school* 0.530 0.209 1.70 1.13–2.56 0.011
HIV stigma* −0.489 0.171 0.61 0.44–0.86 0.004
Number of HIV tests in past year
None Ref – – – –
1* 0.567 0.195 1.76 1.20–2.58 0.004
2+* 1.158 0.198 3.18 2.16–4.69 <.0001
Hazardous/harmful alcohol use* −0.492 0.158 0.61 0.45–0.83 0.002
Total number of partners* 0.040 0.016 1.04 1.01–1.07 0.0111
aAsterisk denotes significance at the .05 level.






























posibilities of social connectedness, or personal beha-
viors that influence health care knowledge and broader
HIV prevention knowledge.
The non-significance of many of the high-risk beha-
viors is noteable. Those who reported high risk behaviors
were not more aware of PrEP, which illustrates that PrEP
information is not reaching populations at high risk.
Findings suggest that specific risk factors do not necess-
arily translate into differential levels of PrEP awareness,
and further research to understand this reationship of
risk perception is important. Increasing awareness and
eventual uptake of PrEP among these subgroups, such
as IV drug users and persons engaging in unprotected
sex, could be beneficial in terms of decreasing HIV inci-
dence among these groups.
This study has some limitations. First, the lack of
measurement of perceived HIV risk prevents us from
making conclusions about its role in determining PrEP
awareness. Additionally, the data were collected through
self-report via in-person interviews, so responses may
have been subject to social desirability bias. Our study
is cross-sectional and thus cannot determine causality
of PrEP awareness, but our description of correlates
nonetheless allows for identification of sub-groups that
would benefit from additional outreach. Also, despite
the inclusion of both black MSM and TGW in the
study, the number of TGW was small, and therefore
our ability to make specific recommendations about
this population is limited.
The study also has several strengths. It included a very
large number of substance-using black MSM and TGW, a
population at high risk of HIV infection, in a geographic
setting that remains an epicenter for HIV infection in the
US (Centers for Disease Control and Prevention, Pub-
lished November 2015). The cohort in this study, with
high rates of poverty, unemployment, and lack of health
insurance, reflect the disparities identified as contributing
to the disproportionate rate of HIV among black MSM
and TGW in the US (Beer, Oster, Mattson, Skarbinski,
& Medical Monitoring Project, 2014; Mayer et al., 2014;
Moore, 2011; Sullivan et al., 2014). Furthermore, this
cohort was recruited from New York City, a high HIV
prevalence area, and over 6% of those tested were diag-
nosed as HIV-infected. The mixed recruitment methods
were also a valuable strength of the study, allowing for
enrollment of a large and diverse sample. This study
adds to the limited literature on PrEP implementation
and HIV prevention among black MSM and TGW.
Conclusion
Awareness of PrEP (or lack thereof) must be taken into
account when implementing PrEP programs. The low
level of PrEP awareness in conjunction with the high
percentage of participants who were diagnosed as HIV-
infected (6.6%) in this study highlights the need for
greater dissemination of PrEP information and edu-
cation to populations at high risk. Black MSM and
TGW account for a disproportionately large number of
newly acquired HIV cases in the US, thus prevention tai-
lored to this group is essential to decreasing HIV inci-
dence. This analysis identified certain subgroups of this
population as having lower PrEP awareness, including
those who did not identify as gay, were older, had hazar-
dous/harmful alcohol use, had greater feelings of stigma
toward others with HIV, and had infrequent prior HIV
testing. Our results suggest that additional efforts to
improve PrEP awareness in this population heavily
impacted by HIV may require moving beyond tra-
ditional gay venues and healthcare settings, such as to
broadly targeted social media and ad campaigns.
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